Edition:
United Kingdom

Aerpio Pharmaceuticals Inc (ARPO.OQ)

ARPO.OQ on NASDAQ Stock Exchange Capital Market

0.65USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$0.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,347
52-wk High
$4.25
52-wk Low
$0.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.209
FY 2018 Dec '18 0.00 -0.209
Sep '18 18.82 0.282
Jun '18 1.33 -0.219
Mar '18 0.00 -0.275
FY 2017 Dec '17 0.00 -0.230
Sep '17 0.00 -0.172
Jun '17 0.00 -0.204
Mar '17 0.00 -0.219
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 2 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-20 4 3.00 10.00 0.00 --
Earnings (per share)
Quarter Ending Sep-19 3 -0.16 -0.12 -0.20 --
Quarter Ending Dec-19 3 -0.16 -0.12 -0.20 --
Year Ending Dec-19 3 -0.69 -0.56 -0.82 --
Year Ending Dec-20 4 -0.54 -0.32 -0.74 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.31 33.85
P/E High - Last 5 Yrs. -- 169.52 54.29
P/E Low - Last 5 Yrs. -- 53.54 28.22
Beta -- 1.29 0.99
Price to Sales (TTM) 1.57 42.65 7.90
Price to Book (MRQ) 0.62 12.25 4.38
Price to Tangible Book (MRQ) 0.62 17.14 5.07
Price to Cash Flow (TTM) -- 64.56 23.70
% Owned Institutions 23.43 3.24 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.67
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.55 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 53.93 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 51.52 8.45
Sales - 5 Yr. Growth Rate -- 33.42 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 23.79 -8.31 19.40
EPS (TTM) vs TTM 1 Yr. Ago 59.55 -- --
EPS - 5 Yr. Growth Rate -- 22.74 7.15
Capital Spending - 5 Yr. Growth Rate -- 26.66 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.52
Current Ratio (MRQ) 13.84 3.87 3.52
LT Debt to Equity (MRQ) 0.00 7.63 12.61
Total Debt to Equity (MRQ) 0.00 20.26 17.64
Interest Coverage (TTM) -- 30.21 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 21.69 50.25
Gross Margin - 5 Yr. Avg. -- 58.96 51.36
EBITD Margin (TTM) -62.01 -- --
EBITD - 5 Yr. Avg -- -12.49 16.42
Operating Margin (TTM) -62.24 -124.67 -6.97
Operating Margin - 5 Yr. Avg. -- -28.74 11.87
Pre-Tax Margin (TTM) -56.87 -126.48 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- -34.06 15.72
Net Profit Margin (TTM) -56.87 -132.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- -38.92 11.11
Effective Tax Rate (TTM) -- 17.21 20.61
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 746,571 10,400,894 870,638,159
Net Income/Employee (TTM) -424,590 2,349,448 101,855,832
Receivable Turnover (TTM) -- 12.32 5.88
Inventory Turnover (TTM) -- 2.26 3.66
Asset Turnover (TTM) 0.58 0.32 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.85 6.26 10.25
Return on Assets - 5 Yr. Avg. -- 6.14 11.17
Return on Investment (TTM) -36.83 7.52 12.69
Return on Investment - 5 Yr. Avg. -- 7.98 14.15
Return on Equity (TTM) -37.04 7.94 17.13
Return on Equity - 5 Yr. Avg. -- 8.90 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 62.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aerpio Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.29 -16.67 22 4
13 Week -25.87 -27.98 30 7
26 Week -80.15 -82.52 4 20
52 Week -80.96 -82.15 9 12
YTD -54.12 -61.99 13 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.43%
# of Holders: 26
Total Shares Held: 9,508,413
3 Mo. Net Change: 10,242
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.